Axonics, Inc. (AXNX) - רווח נקי למניה (EPS TTM)

Axonics, Inc. (AXNX) is strengthening its position through innovative r-SNM systems for bladder therapy. The team is expanding due to aggressive engineering recruitment and generous stock options. This chart of net profit per share over the last 12 months visualizes financial stability, where the value of -1.31 reflects this status. High implant quality is ensured by robotic micro-assembly, which eliminates manual labor during electrode installation.

This indicator measures the portion of net income attributable to a single common share over a rolling year. The current trailing 12-month earnings per share filters out volatile paper revaluations, revealing true capital efficiency. Growth in this metric confirms the business's ability to generate real income. For Axonics, Inc. (AXNX), this reflects the high margins of its neurostimulators. The company's liquidity surplus directly transforms into the strengthening of this fundamental trend.